Clinical and Survival Impact of FDG PET in Patients with Suspicion of Recurrent Ovarian Cancer: A 6-Year Follow-Up.

about

Molecular imaging in ovarian cancer.

P2860

Q38824319-D924053D-C36D-43A9-A9A7-732F405A0975

P2860

Clinical and Survival Impact of FDG PET in Patients with Suspicion of Recurrent Ovarian Cancer: A 6-Year Follow-Up.

Item

http://www.wikidata.org/entity/Q35877090

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Clinical and Survival Impact o ...... an Cancer: A 6-Year Follow-Up.

@ast

Clinical and Survival Impact o ...... an Cancer: A 6-Year Follow-Up.

@en

type

Item

label

Clinical and Survival Impact o ...... an Cancer: A 6-Year Follow-Up.

@ast

Clinical and Survival Impact o ...... an Cancer: A 6-Year Follow-Up.

@en

prefLabel

Clinical and Survival Impact o ...... an Cancer: A 6-Year Follow-Up.

@ast

Clinical and Survival Impact o ...... an Cancer: A 6-Year Follow-Up.

@en

P1476

Clinical and Survival Impact o ...... an Cancer: A 6-Year Follow-Up.

@en

P2093

Caroline Rousseau

http://www.w3.org/2001/XMLSchema#string

Daniela Rusu

http://www.w3.org/2001/XMLSchema#string

Dominique Berton-Rigaud

http://www.w3.org/2001/XMLSchema#string

Dorothée Goulon

http://www.w3.org/2001/XMLSchema#string

Isabelle Jaffre

http://www.w3.org/2001/XMLSchema#string

Mathilde Colombié

http://www.w3.org/2001/XMLSchema#string

Nicolas Rousseau

http://www.w3.org/2001/XMLSchema#string

Thomas Carlier

http://www.w3.org/2001/XMLSchema#string

Vincent Fleury

http://www.w3.org/2001/XMLSchema#string

P2860

New perspectives on targeted therapy in ovarian cancer

The impact of PET-CT in suspected recurrent ovarian cancer: A prospective multi-centre study as part of the Australian PET Data Collection Project.

PET/CT imaging in gynecologic malignancies: a critical overview of its clinical impact and our retrospective single center analysis.

Clinical utility of positron emission tomography/computed tomography in the evaluation of suspected recurrent ovarian cancer in the setting of normal CA-125 levels.

Imaging techniques for the evaluation of ovarian cancer.

Staging recurrent ovarian cancer with (18)FDG PET/CT.

Management of asymptomatic patients on follow-up for ovarian cancer with rising CA-125 concentrations.

Recurrent ovarian cancer: use of contrast-enhanced CT and PET/CT to accurately localize tumor recurrence and to predict patients' survival.

CA 125, PET alone, PET-CT, CT and MRI in diagnosing recurrent ovarian carcinoma: a systematic review and meta-analysis.

Surveillance of patients after initial treatment of ovarian cancer.

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FMED.2015.00046

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Loïc Campion

Françoise Kraeber-Bodéré

P577

2015-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280909017

http://www.w3.org/2001/XMLSchema#string

P698

26258124

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

P932

4510414

http://www.w3.org/2001/XMLSchema#string

Clinical and Survival Impact of FDG PET in Patients with Suspicion of Recurrent Ovarian Cancer: A 6-Year Follow-Up.

about

P2860

P2860

Clinical and Survival Impact of FDG PET in Patients with Suspicion of Recurrent Ovarian Cancer: A 6-Year Follow-Up.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P921

P932